Recent Trends in Product Development and Regulatory Issues on Impurities in Active Pharmaceutical Ingredient (API) and Drug Products. Part 2: Safety Considerations of Impurities in Pharmaceutical Products and Surveying the Impurity Landscape
Journal Title: AAPS PharmSciTech - Year 2014, Vol 15, Issue 1
Abstract
There are inconsistent identification and qualification thresholds for impurities in drug substances and drug products, particularly for degradation impurities that may be common to both a drug substance and a corresponding product. The inconsistencies, expressed as total daily intake (TDI) of an impurity, are magnified at relatively low doses (see Table ​TableII). II ). For example, with a daily dose of 1 mg, the qualification thresholds are 1.5 and 10 μg for impurities in drug substances and drug products, respectively. Should the ICH Q3A and Q3B guidelines be revised to make these thresholds more consistent? Other questions such as differentiating impurity thresholds based on use of the drug (e.g., chronic vs. acute therapy) also remain.
Authors and Affiliations
Karen M. Alsante, Kim C. Huynh-Ba, Steven W. Baertschi, Robert A. Reed, Margaret S. Landis, Scott Furness, Bernard Olsen, Mark Mowery, Karen Russo, Robert Iser, Gregory A. Stephenson, Patrick Jansen
Keywords
Related Articles
- EP ID EP682366
- DOI 10.1208/s12249-013-0061-z
- Views 101
- Downloads 0
Preparation and In Vitro–In Vivo Evaluation of Sustained-Release Matrix Pellets of Capsaicin to Enhance the Oral Bioavailability
Capsaicin has multiple pharmacological activities including antioxidant, anticancer, and anti-inflammatory activities. However, its clinical application is limited due to its poor aqueous solubility, gastric irritation,...
The Improvement of the Dissolution Rate of Ziprasidone Free Base from Solid Oral Formulations
This work aims at increasing solubility and dissolution rate of ziprasidone free base—Biopharmaceutics Classifaction System (BCS) class II compound. The authors describe a practical approach to amorphization and...
Influence of the Component Excipients on the Quality and Functionality of a Transdermal Film Formulation
The influence of formulation variables, i.e., a hydrophilic polymer (Methocel® E15) and a film-forming polymer (Eudragit® RL 100 and Eudragit® RS 100), on the physicochemical and functional proper...
A Risk-Based Approach to Management of Leachables Utilizing Statistical Analysis of Extractables
To incorporate quality by design concepts into the management of leachables, an emphasis is often put on understanding the extractable profile for the materials of construction for manufacturing disposables, container-cl...
The Effect of Streptozotocin and Alloxan on the mRNA Expression of Rat Hepatic Transporters In Vivo
The effect of streptozotocin (STZ) and alloxan (ALX) on the hepatic messenger RNA (mRNA) expression of four transporters (Mrp2, Mdr1, Oct1, and Oatp1) was studied in the present work. After the healthy male Wistar rats w...